Evidence map›Paper›PMID 40761538›Full record

ArticleJournal of toxicology2025

Herbo-Mineral Medicine, Cardiogrit Gold, Exhibits Protective Effects in

Acharya Balkrishna, Saurabh Bhatti, Meenu Tomer, Sudeep Verma, Rishabh Dev, Anurag Varshney

Abstract read
In one paragraph

Article in Journal of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Acharya BalkrishnaDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.
Saurabh BhattiDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.
Meenu TomerDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.
Sudeep VermaDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.
Rishabh DevDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.ORCID https://orcid.org/0000-0002-7878-6934
Anurag VarshneyDrug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.ORCID https://orcid.org/0000-0001-8509-0882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxorubicin, an effective antineoplastic agent, is often prescribed for the treatment of various carcinomas. However, the use of doxorubicin becomes limited due to its adverse effects like cardiotoxicity, dysmenorrhea, and leucopenia. Cardiogrit Gold (CG) is a herbo-mineral Ayurvedic medicine prescribed for the treatment of various cardiovascular ailments. The current study aimed to investigate the therapeutic potential of CG in imparting protection against doxorubicin-induced cardiotoxicity. Wild-type (N2) and genetically modified

Indexed as

Caenorhabditis elegansCardiogrit Goldcardiotoxicitydoxorubicinpharyngeal pumping

Identifiers

PMID40761538
PMCPMC12321421

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.